26
Colorectal cancer:
Clinical studies revealed that 2-year survival of patients after Ukrain therapy is 78.6% compared to 33.3% after conventional chemotherapy [67,112].
Pancreas cancer:
In a recent clinical study of gemcitabine in advanced pancreas cancer no patient survived beyond 19 months* whereas 19-month survival of Ukrain treated patients in another study was 48%** [153].
* Howard A. Burris III at al., J Clin Oncol, Vol 15, 6(June), 1997: pp. 2403-2413.
** with the longest duration of 7 years.
Results of clinical treatment with Ukrain (NSC 631570) (1)